Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Keywords/Phrases:  cholangiocarcinoma
Trial Status:  Active
Results 1-25 of 116 for your search:
Start Over
Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 1111012021, NCT01524146
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: S1vsNab-P20130819, NCT01963325
International Registry on Cholangiocarcinoma Treatment
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CHOLANGIO01, CHOLANGIO100513, NCT01920503
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PIN-PHO1201, NCT02082522
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: RFA2012, NCT01739465
Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SUMS-5010, Cholangiocarcinoma, Surgery, Drainage, NCT00797121
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-020385-13, NCT01206049
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2372P, NCT01549795
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CBGJ398X2204, 2013-005085-19, NCT02150967
Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 20140615, NCT02178280
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: XHDD-004, NCT02108145
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 05-0651 / 201102096, NCT00301379
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2252P, NCT01442324
Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1110011999, NCT01755013
Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H2009/3522, NCT00973713
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PrE0204, AX-CL-OTHER-PrECOG-004080, NCT02181634
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-EB-CHOL-Th, 2012-001213-16, A121007-71, NCT01912053
Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
Phase: No phase specified
Type: Treatment
Status: Active
Age: 17 to 60
Sponsor: Other
Protocol IDs: EHBH-RCT-2013-002-02, NCT01914289
Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 21/2014/U/Tess, NCT02184871
Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 30 to 65
Sponsor: Other
Protocol IDs: P-09-00171, NCT01039181
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: P120106, NCT02232932
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: S4-13-001, NCT02128282
Regorafenib Versus Placebo to Treat Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 2012-005626-30, NCT02162914
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: 15-007, NCT02428855
Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 11-0181, NCT01648023
Start Over